Through computational network analysis, the team revealed multiomics interactions between ZNF71 and intracellular immune response genes, identifying genes with pan-sensitivity or resistance to 21 NCCN-recommended NSCLC therapies. The gene discussed is ZNF71; the disease is non-small cell lung carcinoma.